Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 473-810-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Under the conditions of the test, the test material does not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay and the material is not considered to be a skin sensitiser.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 June 2006 to 11 December 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2004
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: Approximately 9 weeks old
- Weight at study initiation: Mean body weight ± standard deviation of 20.4 ± 1.1 g
- Housing: The animals were housed individually in disposable crystal polystyrene cages (22 x 8.5 x 8 cm). Each cage contained autoclaved sawdust.
- Diet: ad libitum
- Water: ad libitum access to tap water filtered using a 0.22 micron filter
- Acclimation period: at least 5 days before the beginning of the study
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 2 °C
- Humidity: 30 to 70 % (relative)
- Air changes: approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod: 12 hours of light / 12 hours of darkness
IN-LIFE DATES: Not reported - Vehicle:
- other: The vehicle used in the first experiment was DMSO; the vehicle used in the second experiment was propylene glycol
- Concentration:
- - Experiment 1: 0.05, 0.1, 0.25, 0.5 and 1 %
- Experiment 2: 5, 10 and 25 % - No. of animals per dose:
- 4 females per dose
- Details on study design:
- PRE-SCREEN TESTS:
To assess the irritant potential of the test material (through ear thickness measurement), a preliminary test was performed on a small number of animals. The test material was prepared at the concentrations of 1, 2.5, 5 and 10 %. For 3 consecutive days, the animals received applications of 25 μL of the dosage form preparations to the external surface of both ears (one concentration per ear); measurement of the ear thickness (using a micrometer) was performed each day before treatment and 24 hours after the last application. The test material was irritating in the preliminary test at concentrations ≥2.5 %. The highest concentration retained for the first experiment was therefore 1 %. However, following a request from the British Authorities (HSE) a second experiment was performed with a maximum concentration of 25 %.
MAIN STUDY
- Administration of the test material
On days 1, 2 and 3 of each experiment, a dose-volume of 25 μL of the control or dosage form preparations was applied to the dorsal surface of both ears, using an adjustable pipette fitted with a plastic tip.
In order to avoid licking and to ensure an optimised application of the test materials, the animals were placed under light isoflurane anaesthesia during the administration. No massage was performed but the tip was used to spread the preparation over the application sites. No rinsing was performed between each application.
- Proliferation Assay:
On day 6 of each experiment, all animals of all groups received a single intravenous injection of 250 μL of 0.9 % NaCl containing 20 μCi of 3H-methyl-thymidine (3H-TdR; specific activity of 25 Ci/mmol) via the tail vein. Approximately 5 hours later, the animals were killed by cervical dislocation and the auricular lymph nodes were excised. The lymph nodes were pooled for each experimental group.
For each experimental group, a single cell suspension of auricular lymph node cells (ALNC) was prepared by mechanical dissagregation in Petri dishes with the plunger of a syringe.
Cell suspensions were washed with 15 mL of 0.9 % NaCl and pellets obtained were re-suspended in 0.9 % NaCl for numeration of lymphocytes (cellularity) and determination of their viability by exclusion of trypan blue. Each cell suspension was then centrifuged and pellets were precipitated with 3 mL of 5 % (w/v) trichloroacetic acid (TCA) in purified water at +4 °C overnight. After a last centrifugation, the pellets were precipitated with 1 mL of 5 % TCA. Three mL of Ultima Gold® scintillation fluid (Packard) were added in order to measure incorporation of 3H-TdR using β-scintillation counting.
The results were expressed as disintegrations/mn (dpm) per group and per node.
Stimulation Indices (SI) were calculated according to the following formula:
SI = dpm of treated group / dpm of control group (group 1)
- Clinical Examinations
The animals were observed at least once a day during the study for clinical signs, signs of morbidity or mortality. In each experiment, the animals were weighed individually on the first day of the study (day 1) and on the day of sacrifice (day 6).
Ear thickness measurements and recording of local reactions were performed in order to assess any possible irritant effect of the test material, as possible irritancy may be involved in false positive lymphoproliferative responses.
On days 1, 2 and 3 (before application), as well as on day 6 (after sacrifice) of each experiment, the thickness of the left ear of each animal of groups 1 to 6 was measured using a micrometer. No measurement of ear thickness was performed for the animals of the positive control group.
Any irritation reaction (erythema and oedema) was recorded in parallel. Any other observation (coloration, presence of residual test material, etc.) was noted.
The irritation level of the test material was determined as follows: % increase in ear thickness between day 1 and day 3 or 6 of <10 %, 10 to 30 % and >30 % were interpreted as irritation levels I, II and III, respectively. These correspond to non-irritant, slightly irritant and irritant.
INTERPRETATION OF RESULTS
The test material was considered as a skin sensitiser when the SI for a dose group is ≥3. Other relevant criteria such as cellularity, radioactivity levels and ear thickness were also taken into account for the interpretation of results. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- In the positive control groups given HCA at the concentration of 25 % in both experiments 1 and 2, a stimulation index exceeding the threshold value of 3 (SI = 5.32 and 24.65, respectively) were noted. The cellularity index also increased in the positive control groups. The study was therefore considered valid.
- Key result
- Parameter:
- SI
- Value:
- 0.63
- Test group / Remarks:
- 0.05 %
- Remarks on result:
- other: Irritation level I
- Key result
- Parameter:
- SI
- Value:
- 0.78
- Test group / Remarks:
- 0.1 %
- Remarks on result:
- other: Irritation level II
- Key result
- Parameter:
- SI
- Value:
- 0.82
- Test group / Remarks:
- 0.25 %
- Remarks on result:
- other: Irritation level II
- Key result
- Parameter:
- SI
- Value:
- 0.86
- Test group / Remarks:
- 0.5 %
- Remarks on result:
- other: Irritation level II
- Key result
- Parameter:
- SI
- Value:
- 0.86
- Test group / Remarks:
- 1 %
- Remarks on result:
- other: Irritation level II
- Key result
- Parameter:
- SI
- Value:
- 1.13
- Test group / Remarks:
- 5 %
- Remarks on result:
- other: Irritation level I
- Key result
- Parameter:
- SI
- Value:
- 1.13
- Test group / Remarks:
- 10 %
- Remarks on result:
- other: Irritation level I
- Key result
- Parameter:
- SI
- Value:
- 1.29
- Test group / Remarks:
- 25 %
- Remarks on result:
- other: Irritation level I
- Cellular proliferation data / Observations:
- - Systemic clinical signs and mortality: No clinical signs and no mortality were observed during the study, in both experiments.
- Body weight: In both experiments, the body weight change of the treated animals was similar to that of the control animals.
- Local irritation: In the first experiment, 13/20 treated animals showed a dryness of the skin of the ears on day 6. A very slight increase in ear thickness was observed in the animals at the concentrations of 0.1, 0.25 and 0.5 %, without clear evidence of dose-response relationship.
In the second experiment, no cutaneous reactions and no noteworthy increase in the ear thickness were observed in the animals of the treated groups.
- Proliferation assay: In both experiments, the incorporation of 3H-TdR in the vehicle control group was as specified in acceptance criteria, the quantity of cells obtained in each group was satisfactory and the cell viability in each group was higher than 80 %. The study was therefore considered valid.
In both experiments, no noteworthy lymphoproliferation was noted at any of the tested concentrations. - Interpretation of results:
- other: Not classified in accordance with EU criteria
- Conclusions:
- Under the conditions of the test, the test material does not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay and the material is not considered to be a skin sensitiser.
- Executive summary:
The potential of the test material to act as a skin sensitiser was investigated in accordance with the standardised guidelines OECD 429 and EU Method B.42 under GLP conditions.
Following a preliminary test, the test material was tested in two independent experiments in female CBA/J mice.
In the first experiment, the test material was tested at the concentrations of 0.05, 0.1, 0.25, 0.5 and 1 % in DMSO on groups of 4 mice per dose level. At the request of the UK Competent Authority (HSE), the test material was tested in a second experiment at higher concentrations of 5, 10 and 25 % in propylene glycol. Concurrent positive (HCA) and negative (vehicle) controls were carried out.
In each experiment, the test material, vehicle or positive control was applied over the ears (25 μL per ear) for three consecutive days (days 1, 2 and 3). After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The obtained values were used to calculate stimulation indices (SI). The irritant potential of the test material was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6.
In the first experiment, no mortality and no clinical signs were observed during the study. Almost all the treated animals showed a dryness of the skin of the ears on day 6. A very slight increase in ear thickness was observed in the animals at the concentrations of 0.1, 0.25 and 0.5 %, without clear evidence of dose-response relationship. No lymphoproliferation was noted at any tested concentration, while significant lymphoproliferation was observed with HCA at 25 %. The SI values were 0.63, 0.78, 0.82, 0.86 and 0.86 at concentrations of 0.05, 0.1, 0.25, 0.5 and 1 %, respectively.
In the second experiment, no mortality and no clinical signs were observed during the study. No cutaneous reactions and no noteworthy increase in ear thickness were observed in the animals of the treated groups. No noteworthy lymphoproliferation was noted at any of the tested concentrations, while significant lymphoproliferation was observed with HCA at 25 %. The SI values were 1.13, 1.13 and 1.29 at 5, 10 and 25 %, respectively.
Under the conditions of the test, the test material does not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay and the material is not considered to be a skin sensitiser.
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Referenceopen allclose all
Table 1: Study Results
Conc. (%) |
Cell Count |
Viability (%) |
Amount of cells (x10^6 cells) |
Cellularity Index |
No. of nodes / group |
dpm / group |
dpm / node |
SI |
Irritation level |
|
Viable |
Dead |
|||||||||
Experiment 1 |
||||||||||
Vehicle |
272 |
30 |
90.07 |
13.60 |
- |
8 |
812.31 |
101.54 |
- |
- |
0.05 |
138 |
19 |
87.90 |
6.90 |
0.51 |
8 |
509.35 |
63.67 |
0.63 |
I |
0.1 |
158 |
18 |
89.77 |
7.90 |
0.58 |
8 |
637.29 |
79.66 |
0.78 |
II |
0.25 |
219 |
6 |
97.33 |
10.95 |
0.81 |
8 |
664.84 |
83.11 |
0.82 |
II |
0.5 |
193 |
28 |
87.33 |
9.65 |
0.71 |
8 |
696.59 |
87.07 |
0.86 |
II |
1 |
190 |
9 |
95.48 |
9.50 |
0.70 |
8 |
697.13 |
87.14 |
0.86 |
II |
HCA |
365 |
39 |
90.35 |
36.50 |
2.68 |
8 |
4321.06 |
540.13 |
5.32 |
- |
Experiment 2 |
||||||||||
Vehicle |
106 |
10 |
91.38 |
10.60 |
- |
8 |
355.09 |
44.39 |
- |
- |
5 |
80 |
17 |
82.47 |
8.00 |
0.75 |
8 |
401.91 |
50.24 |
1.13 |
I |
10 |
80 |
11 |
87.91 |
8.00 |
0.75 |
8 |
399.50 |
49.94 |
1.13 |
I |
25 |
131 |
4 |
97.04 |
13.10 |
1.24 |
8 |
456.54 |
57.07 |
1.29 |
I |
HCA |
539 |
29 |
94.89 |
53.90 |
5.08 |
8 |
8753.25 |
1094.16 |
24.65 |
- |
Viability = [viable cells / (viable cells + dead cells)] x 100
Cellularity index = amount of cells (x 10^6 cells) in the treated group / amount of cells (x 10^6 cells) in the vehicle group
Stimulation index = dpm of treated group / dpm of control group
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The potential of the test material to act as a skin sensitiser was investigated in accordance with the standardised guidelines OECD 429 and EU Method B.42 under GLP conditions. The study was awarded a reliability score of 1 in accordance with the criteria set forth by Klimisch et al. (1997).
Following a preliminary test, the test material was tested in two independent experiments in female CBA/J mice.
In the first experiment, the test material was tested at the concentrations of 0.05, 0.1, 0.25, 0.5 and 1 % in DMSO on groups of 4 mice per dose level. At the request of the UK Competent Authority (HSE), the test material was tested in a second experiment at higher concentrations of 5, 10 and 25 % in propylene glycol. Concurrent positive (HCA) and negative (vehicle) controls were carried out.
In each experiment, the test material, vehicle or positive control was applied over the ears (25 μL per ear) for three consecutive days (days 1, 2 and 3). After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The obtained values were used to calculate stimulation indices (SI). The irritant potential of the test material was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6.
In the first experiment, no mortality and no clinical signs were observed during the study. Almost all the treated animals showed a dryness of the skin of the ears on day 6. A very slight increase in ear thickness was observed in the animals at the concentrations of 0.1, 0.25 and 0.5 %, without clear evidence of dose-response relationship. No lymphoproliferation was noted at any tested concentration, while significant lymphoproliferation was observed with HCA at 25 %. The SI values were 0.63, 0.78, 0.82, 0.86 and 0.86 at concentrations of 0.05, 0.1, 0.25, 0.5 and 1 %, respectively.
In the second experiment, no mortality and no clinical signs were observed during the study. No cutaneous reactions and no noteworthy increase in ear thickness were observed in the animals of the treated groups. No noteworthy lymphoproliferation was noted at any of the tested concentrations, while significant lymphoproliferation was observed with HCA at 25 %. The SI values were 1.13, 1.13 and 1.29 at 5, 10 and 25 %, respectively.
Under the conditions of the test, the test material does not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay and the material is not considered to be a skin sensitiser.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.